A VERY ELDERLY WOMAN EXPERIENCING Two EPISODES OF ACUTE MYOCARDIAL INFARCTION TREATED BY PERCUTANEOUS CORONARY INTERVENTION: A CASE REPORT AND LITERATURE REVIEW

被引:1
作者
Sung, Li-Chin [1 ,3 ]
Wang, Ji-Hung [1 ,2 ]
机构
[1] Buddhist Tzu Chi Gen Hosp, Dept Internal Med, Div Cardiol, Hualien, Taiwan
[2] Tzu Chi Univ, Hualien, Taiwan
[3] Taipei Med Univ, Shuang Ho Hosp, Div Cardiovasc Med, Taipei, Taiwan
关键词
elderly; myocardial infarction; percutaneous transluminal coronary angioplasty; HEALTH-CARE PROFESSIONALS; HEART-ASSOCIATION COUNCIL; THROMBOLYTIC THERAPY; SCIENTIFIC STATEMENT; GERIATRIC-CARDIOLOGY; CLINICAL CARDIOLOGY; NONAGENARIANS; OUTCOMES; COLLABORATION; SOCIETY;
D O I
10.1016/S1873-9598(10)70039-9
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Advanced age is associated with poor outcome among patients with acute myocardial infarction (AMI). It appears that elderly patients are treated more conservatively because of multiple comorbidities and higher risk of further invasive therapy. Reperfusion therapy for AMI may improve survival, and previous studies have shown that patients receiving percutaneous coronary intervention (PCI) have better clinical outcomes than those given thrombolytic therapy. We report our experience with a 96-year-old woman with anteroseptal wall ST-segment elevation myocardial infarction successfully treated with primary PCI. One stent was implanted in the left anterior descending artery occlusive lesion. The patient survived and was discharged from the hospital 7 days later. She received optimal medical therapy and had no major adverse cardiac events within 1 year. Unfortunately, the patient had non-ST-segment elevation myocardial infarction 18 months later. We discussed with her family about the risk/benefit ratio of PCI, and they agreed with the procedure. We performed PCI successfully and the patient was discharged 5 days later. No major adverse cardiac events occurred within 4 months. In very elderly patients without multiple comorbidities, PCI is safe for AMI and effective in shortening hospital stay, reducing in-hospital and short-term mortality. We also discuss our strategy for this very elderly patient and the present therapy for AMI in nonagenarians. [International Journal of Gerontology 2010; 4(3): 148-153]
引用
收藏
页码:148 / 153
页数:6
相关论文
共 18 条
  • [11] Effectiveness of percutaneous coronary interventions in nonagenarians
    Moreno, R
    Salazar, A
    Bañuelos, C
    Hernández, R
    Alfonso, F
    Sabaté, M
    Escaned, J
    Pérez, MJ
    Azcona, L
    Macaya, C
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (08) : 1058 - 1060
  • [12] Is age an independent determinant of mortality in cardiac surgery assuggested by the EuroSCORE?
    Mortasawi A.
    Arnrich B.
    Rosendahl U.
    Frerichs I.
    Albert A.
    Walter J.
    Ennker J.
    [J]. BMC Surgery, 2 (1) : 1 - 8
  • [13] Multicenter experience in revascularization of very elderly patients
    Peterson, ED
    Alexander, KP
    Malenka, DJ
    Hannan, EL
    O'Conner, GT
    McCallister, BD
    Weintraub, WS
    Grover, FL
    [J]. AMERICAN HEART JOURNAL, 2004, 148 (03) : 486 - 492
  • [14] Results of percutaneous coronary interventions in patients ≥90 years of age
    Teplitsky, Igal
    Assali, Abid
    Lev, Eli
    Brosh, David
    Vaknin-Assa, Hana
    Kornowski, Ran
    [J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2007, 70 (07) : 937 - 943
  • [15] Incidence and predictors of bleeding events after fibrinolytic therapy with fibrin-specific agents - A comparison of TNK-tPA and rt-PA
    Van de Werf, F
    Barron, HV
    Armstrong, PW
    Granger, CB
    Berioli, S
    Barbash, G
    Pehrsson, K
    Verheugt, FWA
    Meyer, J
    Betriu, A
    Califf, RM
    Li, X
    Fox, NL
    [J]. EUROPEAN HEART JOURNAL, 2001, 22 (24) : 2253 - 2261
  • [16] Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting -: The assessment of the safety and efficacy of a new thrombolytic regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarction
    Wallentin, L
    Goldstein, P
    Armstrong, PW
    Granger, CB
    Adgey, AAJ
    Arntz, HR
    Bogaerts, K
    Danays, T
    Lindahl, B
    Mäkijärvi, M
    Verheugt, F
    Van de Werf, F
    [J]. CIRCULATION, 2003, 108 (02) : 135 - 142
  • [17] Age and outcome with contemporary thrombolytic therapy - Results from the GUSTO-I trial
    White, HD
    Barbash, GI
    Califf, RM
    Simes, RJ
    Granger, CB
    Weaver, WD
    Kleiman, NS
    Aylward, PE
    Gore, JM
    Vahanian, A
    Lee, KL
    Ross, AM
    Topol, EJ
    [J]. CIRCULATION, 1996, 94 (08) : 1826 - 1833
  • [18] Wu Y-J, 2004, ACTA CARDIOL SIN, V20, P73